IRONWOOD PHARMACEUTICALS, INC.: diluted weighted-average shares

What this measure means

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Exact concept: us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2009-01-01 to 2025-12-31. The SEC response was captured on 2026-09-20.

Selected filing history

Related financial histories

• IRONWOOD PHARMACEUTICALS, INC.: total assets
• IRONWOOD PHARMACEUTICALS, INC.: stockholders equity
• IRONWOOD PHARMACEUTICALS, INC.: cash and cash equivalents
• IRONWOOD PHARMACEUTICALS, INC.: net income or loss
• IRONWOOD PHARMACEUTICALS, INC.: operating cash flow
• IRONWOOD PHARMACEUTICALS, INC.: capital expenditure payments
• IRONWOOD PHARMACEUTICALS, INC.: revenue
• IRONWOOD PHARMACEUTICALS, INC.: contract revenue excluding tax
• IRONWOOD PHARMACEUTICALS, INC.: financing cash flow
• IRONWOOD PHARMACEUTICALS, INC.: investing cash flow
• IRONWOOD PHARMACEUTICALS, INC.: retained earnings or deficit
• IRONWOOD PHARMACEUTICALS, INC.: basic weighted-average shares
• IRONWOOD PHARMACEUTICALS, INC.: basic earnings per share
• IRONWOOD PHARMACEUTICALS, INC.: diluted earnings per share
• IRONWOOD PHARMACEUTICALS, INC.: income tax expense or benefit
• IRONWOOD PHARMACEUTICALS, INC.: net property, plant and equipment
• IRONWOOD PHARMACEUTICALS, INC.: share-based compensation expense
• IRONWOOD PHARMACEUTICALS, INC.: operating income or loss
• IRONWOOD PHARMACEUTICALS, INC.: current assets
• IRONWOOD PHARMACEUTICALS, INC.: interest expense
• IRONWOOD PHARMACEUTICALS, INC.: current liabilities
• IRONWOOD PHARMACEUTICALS, INC.: current accounts payable
• IRONWOOD PHARMACEUTICALS, INC.: net finite-lived intangible assets
• IRONWOOD PHARMACEUTICALS, INC.: net current accounts receivable
• IRONWOOD PHARMACEUTICALS, INC.: operating expenses
• IRONWOOD PHARMACEUTICALS, INC.: net inventory
• IRONWOOD PHARMACEUTICALS, INC.: cost of revenue
• IRONWOOD PHARMACEUTICALS, INC.: selling, general and administrative expense
• IRONWOOD PHARMACEUTICALS, INC.: research and development expense

Inspect the source

Entity

IRONWOOD PHARMACEUTICALS, INC. / CIK 0001446847

Captured

2026-09-20T09:04:45.983Z

SEC response SHA-256

e907547bc46d38e028ac317d678e19520bc4135085f9133b1b1f54dc9a6016a4

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001446847.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))